Argenta Discovery Ltd. Company Profile

14:26 EDT 17th March 2018 | BioPortfolio

Argenta Discovery is a privately held drug discovery company, applying its integrated medicinal chemistry, biology, ADMET and CADD expertise to drive drug discovery programmes. Argenta has a successful contract research business, offering complete drug discovery services in many therapeutic areas to pharmaceutical and biotech clients. We provide resources and expertise to direct complete discovery programmes, from hit compound to candidate, and also undertake discrete hit identification, hit-to-lead, and lead optimisation projects, utilising our state-of-the-art scientific capabilities and drug discovery experience.


8/9 Spire Green CentreFlex Meadow
CM19 5TR
United Kingdom


Phone: 44 (0)1279 645645
Fax: 44 (0)1279 645646

News Articles [322 Associated News Articles listed on BioPortfolio]

PTV News: Feb 3rd, 2010

Top stories on February 3rd, 2010: Roche profits plummet after Genentech integration costs Spectrum analysis: TopoTarget’s belinostat viewed as good bet Amgen battles Teva over generic Neupogen C...

Blue Oak and PsychoGenics partner on drug discovery

Blue Oak Pharmaceuticals and PGI Drug Discovery have entered into a partnership to discover and optimize novel treatments for brain disorders and psychiatric conditions. Under the terms of the agreeme...

BRIEF—UK’s Medicines Discovery Catapult in new AMR project

The Medicines Discovery Catapult, the UK government-backed body that seeks to speed drug discovery and…

How Robot Math and Smartphones Led Researchers to a Drug Discovery Breakthrough

NewsResearchers have figured out how to apply an algorithm originally designed to help robots move to an entirely different problem: drug discovery.

Beacon Discovery, Janssen team up in metabolic conditions

Beacon Discovery Inc. and Janssen Pharmaceuticals Inc. are teaming up in the discovery of small molecules aimed at various G-protein coupled receptor (GPCR) targets for metabolic diseases.

X-Chem, AstraZeneca expand drug discovery partnership

X-Chem, a small molecule discovery specialist, has expanded its existing global drug discovery and technology transfer collaboration with AstraZeneca.

The Current issue of “The view from here” is concerned with nanoscience in drug discovery.

The topic of this month’s newsletter from Drug Discovery Today is “nanoscience in drug discovery”

Beacon enters drug discovery collaboration with Janssen

US-based drug discovery firm Beacon Discovery has entered a multi-year collaboration agreement with Janssen Pharmaceuticals for small molecule compounds to...Read More... The post Beacon enters drug d...

PubMed Articles [550 Associated PubMed Articles listed on BioPortfolio]

Protac-induced Protein Degradation in Drug Discovery: Breaking the Rules - or Just Making New Ones?

Targeted protein degradation, using bifunctional small molecules (Protacs) to remove specific proteins from within cells, has emerged as a novel drug discovery strategy with the potential to offer the...

From machine learning to deep learning: progress in machine intelligence for rational drug discovery.

Machine intelligence, which is normally presented as artificial intelligence, refers to the intelligence exhibited by computers. In the history of rational drug discovery, various machine intelligence...

Fragment-Based Drug Discovery of Phosphodiesterase Inhibitors.

Phosphodiesterases are proving to be fruitful targets for drug discovery. At the same time fragment-based drug discovery has matured into a powerful and widely applied technique. In this communication...

The Current State of Peptide Drug Discovery: Back to the Future?

Over the last decade, peptide drug discovery has experienced a revival of interest and scientific momentum, as the pharmaceutical industry has come to appreciate the role that peptide therapeutics can...

Allosteric Tuning of Caspase-7: a Fragment-Based Drug Discovery Approach.

The caspase family of cysteine proteases are highly sought after drug targets due to their essential roles in apoptosis, proliferation and inflammation pathways. High throughput screening efforts to d...

Clinical Trials [159 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Biologic Basis of Liver Cancer From Chronic Hepatitis B

The focus of the study is to identify viral factors and host immune responses that differentiate HBV-related HCC patients from HBV patients who have not progressed to HCC. To that end, the...

Companies [1079 Associated Companies listed on BioPortfolio]

Argenta Discovery

Argenta Discovery is a new United Kingdom-based company (established 2000) dedicated to the production of high-quality lead series, suitable for development as potential pharmaceuticals. Argenta scien...

Argenta Discovery Ltd.

Argenta Discovery is a privately held drug discovery company, applying its integrated medicinal chemistry, biology, ADMET and CADD expertise to drive drug discovery programmes. Argenta has a successfu...

Discovery Health

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets, including, as well as its Continuing Medical Education (CME) business and ...

Pyxis Discovery B.V.

The ambition of Pyxis Discovery is to be the preferred chemistry service provider for companies that are active in small molecule drug discovery. Pyxis Discovery's Smart approach of designing and ...

Med Discovery SA

Med Discovery’s mission is the discovery and development of highly specific protein drugs to treat uro-genital cancers. By combining biological drug discovery expertise with a strong in-house knowle...

More Information about "Argenta Discovery Ltd." on BioPortfolio

We have published hundreds of Argenta Discovery Ltd. news stories on BioPortfolio along with dozens of Argenta Discovery Ltd. Clinical Trials and PubMed Articles about Argenta Discovery Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Argenta Discovery Ltd. Companies in our database. You can also find out about relevant Argenta Discovery Ltd. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record